Trevena Investors Ink $8.5M Deal Over Painkiller Claims

A class believed to consist of thousands of Trevena investors asked a Pennsylvania federal judge on Monday to grant final approval of an $8.5 million settlement, which would resolve claims that...

Already a subscriber? Click here to view full article